跳至主要内容
临床试验/NCT03091608
NCT03091608Unknown不适用

A Registry Study to Surveil Early Liver Injuries Caused by Xianlin Gubao Granule (XLGB Granule)

Beijing 302 Hospital1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2017年3月25日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
1,000
试验地点
1
主要终点
The detection of patients with serum liver biochemistry abnormalities within 8 weeks after intake of XLGB Granule.

研究概览

简要总结

This is a prospective registry study to surveil early liver injuries caused by Xianlin Gubao Granule (XLGB Granule) through a non-intervention observational way. And attempt to establish a predictive model to screen susceptibilities to XLGB Granule.

详细描述

The primary objectives of this study include:

(i) The detection of patients with serum liver biochemistry abnormalities within 8 weeks after intake of XLGB Granule; (ii) The record of overall individuals with demographics, underlying diseases, physical status, medication information, clinical laboratory index, and so on; (iii) The specimen collection of surveiled individuals. (iv) The attempt to establish a predictive model to screen susceptibilities to XLGB Granule.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals in accordance with indications for XLGB Granule, including osteoporosis, fracture, osteoarthritis, aseptic necrosis of bone and climacteric;
  • The age range of 18 to 70 years;
  • Individuals taking XLGB Granule over 2 weeks;
  • Abnormalities of serum liver biochemistry achieving one of the criteria as follows:
  • (i) alanine aminotransaminase (ALT) or aspartate transaminase (AST) ≥2 folds of upper limit of normal (ULN); (ii) total bilirubin (TBiL) ≥ 2 ULN; (iii) alkaline phosphatase (ALP) ≥ 2 ULN;
  • Individuals can provide informed consent form.

排除标准

  • Individuals without indications for XLGB Granule;
  • Unconformity to the XLGB Granule drug label;
  • Individual taking XLGB Granule less than 2 weeks;
  • Individuals taking other hepatotoxic drugs combined with XLGB Granule, simultaneously;
  • Unconformity to the diagnostic standard for herb-induced liver injury (the Guideline for Diagnosis and Treatment of Herb-induced Liver Injury, RPGIP-2016CN003).

结局指标

主要结局

The detection of patients with serum liver biochemistry abnormalities within 8 weeks after intake of XLGB Granule.

时间窗: participants will be followed duration intake of XLGB Granule, an expected average within 8 weeks

The detection of patients with serum liver biochemistry abnormalities within 8 weeks after intake of XLGB Granule.

次要结局

  • Clinical features of early liver injuries caused by XLGB Granule assessed by serum parameters of liver function.(participants will be followed duration intake of XLGB Granule, an expected average of 8 weeks)

研究者

发起方
Beijing 302 Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiaohe Xiao

Director

Beijing 302 Hospital

研究点 (1)

Loading locations...

相似试验